PouchDaily topic
US nicotine-pouch regulation, FDA decisions, market developments and company news.
science
Who starts nicotine pouches — and who stops: new US cohort dataA new preprint using nationally representative PATH data (2022–2024) finds nicotine pouch initiation is heavily concentrated among people who already use other tobacco products — smokeless users were over 40 times more likely to start than non-users — while most adults never touch the category.
market
Imperial's first update since buying Helwit: double-digit NGP growth, £1.5bn more buybacksImperial Brands' FY26 pre-close trading update is the first company results to include the Helwit and Black Buffalo acquisitions. It guides to double-digit NGP net revenue growth and a new £1.5 billion share buyback — though pouch-specific figures stay inside the combined NGP line.
science
New federal study: nicotine pouch users are young, female and college-educated — not the smokeless crowdPATH Study wave 7 data on 29,705 US adults: 1.4% used nicotine pouches in the past 30 days, and pouch users skew 18–24, female and college-educated — a completely different profile than snus and smokeless tobacco users.
science
Scientists reviewed 73 new nicotine pouch studies. Here's the full picture.An updated scoping review in Nicotine & Tobacco Research covers 73 new pouch studies: US youth use hit 1.8%, adult sales tripled since 2021, high-strength pouches deliver more nicotine than cigarettes — and pouches remain considerably less toxic than cigarettes, with long-term effects still unknown.
regulation
Digital ID checks are coming to 20,000+ US checkout systems — nicotine pouches includedNCR Voyix and NACS have integrated TruAge digital age verification across platforms serving about 75% of US convenience retail — starting with 20,000+ stores. Nicotine pouch sales are squarely in scope.
market
BAT just mapped out 2030 — and Velo Plus is now 30% of the US pouch marketAt its Capital Markets Day, BAT put modern oral at the center of Horizon 2030: mid-teens New Category revenue growth, 30% contribution margin by 2030, and Velo Plus at a 30% US share as the No. 2 behind ZYN.
trend
Smokeless tobacco use among North Dakota teens doubled in two years — and pouches are the suspectThe state's 2025 Youth Risk Behavior Survey shows past-30-day smokeless use rising from 3% to 7% among high schoolers, while vaping declined. Health officials point to nicotine pouches: easy to hide, 'tobacco-free' on the label.
regulation
Congress's audit wing just put a number on FDA's pouch backlog: 132,000 products, 3.5 years and countingA new GAO audit found 131,915 tobacco product applications still waiting for a final FDA decision at the end of 2025 — pending applications had waited an average of 1,266 days against a 180-day statutory goal. It also confirms FDA's nicotine pouch pilot is now the template for how other categories get reviewed.
regulation
FDA wants to replace the PMTA rule that decides which pouches are legal — and open up in the processThe FDA says it plans new rulemaking to replace the PMTA framework, citing an illicit market, a federal lawsuit and a flood of new products — while publishing a transparency roadmap.
market
Full Send pouches are now on GoPuff — NELK's brand goes from DTC to 30-minute deliveryFull Send's own site now advertises on-demand delivery through GoPuff in as fast as 30 minutes, no subscription required. It's the first retail channel beyond the brand's own store.
science
The biggest evidence review on nicotine pouches just got bigger — 135 studies, one clear bottom lineAn updated Georgetown-led scoping review adds 73 studies to its evidence base: pouches are considerably less toxic than cigarettes, higher-strength pouches deliver more nicotine than a cigarette, and the quit evidence remains thin.
regulation
What FDA's modified-risk order for ZYN actually allows — and what it doesn'tIn June 2026, FDA let 20 ZYN pouches carry a reduced-risk claim versus cigarettes — the first ever for nicotine pouches. Here's what the order covers, what it requires, and why it's a precedent.
market
BAT commits to mid-teens New Category growth through 2030 — with Velo front and centerAt its Capital Markets Day in Winston-Salem, BAT targeted mid-teens New Category revenue growth and a 30%+ contribution margin by 2030, while guiding 2026 growth to the lower end of its ranges.
science
Researchers read 73 new nicotine pouch studies. Here's what the big picture looks like nowAn NIH- and FDA-funded team pulled 73 new studies into one review: youth use creeping up, adult use low, sales tripling — and stronger pouches delivering nicotine faster than cigarettes.
market
ZYN Dry Pouches Now Come in Four Strengths — and the Can Is About to Get BiggerPMI U.S. is adding 1.5 mg and 8 mg options to the flagship ZYN dry lineup and moving 3 mg and 6 mg cans to 20 pouches in Q4 — the widest strength range the brand has shipped in the US.
market
Altria and PMI sign manufacturing deal — cigarette tax savings earmarked for smoke-free and pouch investmentThe two companies behind ZYN and on! — the largest U.S. nicotine pouch brands — have signed a contract manufacturing deal for cigarettes. The financial logic is a tax rebate on exports, but Altria says the savings will fund its smoke-free Vision, including nicotine pouches.
market
FRE lets customers pick its next nicotine pouch flavorsFRE — the Turning Point Brands nicotine pouch brand — launched FRE Labs, a limited-edition flavor platform where adult consumers vote on which small-batch flavors join the permanent lineup. The first drop, Blackberry Lemon Ice, is part of a new "Ice" line in 6mg and 12mg strengths, sold online only.
market
ALP's biggest flavor launch yet: 3 limited-edition pouchesALP — the Tucker Carlson-backed pouch brand owned by Turning Point Brands — has launched the Frontier Collection: three new limited-edition flavors (Cowboy Coffee, Campfire Cinnamon, Sunset Mango) in 4mg and 8mg strengths. The brand calls it its biggest release to date, backed by a Western-themed campaign with creator Dave "Heavy D" Sparks.
market
On! Pouch Volume Hits 47.2M Cans — But Share Still Falls as ZYN and Velo Outpace Altria's GrowthAltria's On! Plus rollout drove Q2 volume to 47.2 million cans, yet On!'s retail share dropped to 13.9% in H1 2026 (down from 16.8% a year earlier) as the $13.4B pouch category grows faster than On! can capture it.
regulation
New York's 75% nicotine pouch tax starts September 1Starting September 1, 2026, New York extends its 75% wholesale tobacco tax to nicotine pouches — treating Zyn, On!, and Velo like cigars even though they contain no tobacco. Every seller must be licensed as a tobacco dealer, and a floor tax on existing inventory is due September 21.
trend
LUCY embedded its nicotine pouches inside a Twitch streamer's 3D characterNicotine pouch brand LUCY signed a multi-year deal with TheBurntPeanut — 2.4 million Twitch followers — embedding LUCY Breakers into a custom holster on his 3D character model across six platforms. It is not a sponsored segment. It is canon. And it lands as regulators in the UK and US are shutting the traditional advertising doors pouch brands used to walk through.
regulation
FDA greenlights 11 ZYN Ultra pouches — including its first 11mgOn 21 August 2026 the FDA issued Marketing Granted Orders for 11 ZYN Ultra nicotine pouches from Swedish Match USA — ten 9mg flavours and a new 11mg Smooth. The authorizations push the total of FDA-authorized nicotine pouch products to 43, with 23 cleared through the agency’s nicotine pouch pilot program. The American Lung Association attacked the move, citing youth appeal.
regulation
FDA lets ZYN claim it’s safer than cigarettes — doctors push backThe FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products on 30 June 2026 — the first time any nicotine pouch has been cleared to advertise reduced disease risk versus cigarettes. The authorised claim covers mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Public health experts say the labelling could normalise nicotine for new users — and point to 460,000 youth pouch users as evidence the category is already reaching kids.
wellbeing
The wellness rebrand of nicotine pouches — and why doctors are pushing backDave Asprey says nicotine can reverse Alzheimer's. Tucker Carlson called ZYN 'lifesaving.' A wave of wellness influencers is reframing nicotine pouches as a 'natural' health hack — and researchers say the claims are outpacing the evidence by a wide margin.
market
NELK's FULL SEND nicotine pouches sold out on launch day — 70% took a subscriptionNELK's FULL SEND brand entered the nicotine pouch market with 8 flavors and 4mg/8mg strengths, US-made and sold direct. The soft launch sold out, and 7 in 10 buyers locked in a monthly subscription before inventory cleared.
regulation
Court clips FDA’s tobacco authority — nicotine pouch rules could be nextA federal appeals court ruled the FDA exceeded its authority by requiring 11 graphic cigarette warnings — Congress only authorized nine. The same legal theory — that the agency went beyond what Congress allowed — is being used to challenge the FDA’s nicotine pouch enforcement guidance in a separate lawsuit.
science
Altria-funded study: smokers who switched to on! pouches saw gum inflammation drop 28%A 24-week randomised trial funded by Altria found that adult smokers who switched to on! nicotine pouches had significantly less gum inflammation, bleeding, and tooth staining than those who kept smoking. Every author is an Altria employee or paid consultant — so the caveats matter as much as the results.
science
Nicotine pouches rank lowest for heart risk — but still not safeA review in Nature Reviews Cardiology maps a hierarchy of vascular harm across every nicotine product. Nicotine pouches sit at the bottom — least harmful among nicotine products — but impair endothelial function, raise oxidative stress and arterial stiffness, and have no long-term outcome data.
wellbeing
The nicotine pouch format is going nicotine-freeThe pouch delivery mechanism that Zyn made famous is now being copied by wellness brands — minus the nicotine. Ultra raised $11M and sold a million cans in six months. Blip, IQ Pouch, and Plopii are all betting the format works for focus, sleep, and calm.
regulation
Trump's FDA pick will decide the fate of unauthorized nicotine pouchesTrump has tapped White House health aide Dr. Heidi Overton to run the FDA. She'd inherit a controversial policy that lets some unauthorized nicotine pouches stay on sale while their applications sit pending — and she hasn't said whether she'd keep it.